Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
activist investor
Biotech
Activist investor fails to derail Alumis' Acelyrin merger
Acelyrin’s shareholders have decided to power ahead with the merger despite the best efforts of an activist investor to sink the deal.
James Waldron
May 14, 2025 7:45am
Dynavax's feud with investor heats up ahead of annual meeting
May 12, 2025 7:15am
Elevation faces activist investor demands to wind down
Apr 17, 2025 10:00am
Keros mulls sale, strengthens defense against activist investors
Apr 10, 2025 8:44am
Cyclacel sheds clinical asset in effort to stop cash spiral
Apr 2, 2025 6:01pm
Investor pumps $3M into Cyclacel in return for CEO role
Jan 3, 2025 10:50am